This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2018-2023.
Company Filing History:
Years Active: 2018-2023
Title: Innovations by Lucy Xu
Introduction
Lucy Xu is a prominent inventor based in Woodcliff Lake, NJ (US). She has made significant contributions to the field of cancer treatment through her innovative research and development. With a total of 2 patents, her work focuses on improving therapeutic outcomes for patients with thyroid and kidney cancers.
Latest Patents
Lucy Xu's latest patents include groundbreaking biomarkers for predicting and assessing the responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds. These biomarkers are predictive of a subject's responsiveness to therapies that include lenvatinib or its pharmaceutically acceptable salts, such as lenvatinib mesylate. The methods and compositions described in her patents are instrumental in selecting appropriate treatment modalities for individuals diagnosed with cancer, suspected of having cancer, or at risk of developing cancer.
Career Highlights
Lucy Xu is currently associated with Eisai R&D Management Co., Ltd., where she continues to advance her research in oncology. Her work has garnered attention for its potential to enhance patient care and treatment efficacy in cancer therapy.
Collaborations
Some of her notable coworkers include Tadashi Kadowaki and Yasuhiro Funahashi, who contribute to her research endeavors and collaborative projects.
Conclusion
Lucy Xu's innovative work in cancer biomarkers exemplifies her commitment to improving treatment options for patients. Her contributions are paving the way for more effective therapies in the fight against cancer.